NCT02231450View on ClinicalTrials.gov

Pharmacokinetics Properties of Single Oral Dosing of Lu AE58054 in Subjects With Hepatic Impairment (Mild and Moderate) and in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2015

Conditions
Heptic Impairment
Interventions
DRUG

Lu AE58054 encapsulated film-coated tablets

Trial Locations (1)

Unknown

APEX GmbH, Munich

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02231450 - Pharmacokinetics Properties of Single Oral Dosing of Lu AE58054 in Subjects With Hepatic Impairment (Mild and Moderate) and in Healthy Subjects | Biotech Hunter | Biotech Hunter